HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Oka Selected Research

5- bromo- N- (1- ethyl- 4- methylhexahydro- 1H- 1,4- diazepin- 6- yl)- 2- methoxy- 6- methylamino- 3- pyridinecarboxamide 2-fumarate

11/2001Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets.
5/2001The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Oka Research Topics

Disease

26Neoplasms (Cancer)
12/2014 - 01/2000
6Stomach Neoplasms (Stomach Cancer)
03/2016 - 07/2000
6Lung Neoplasms (Lung Cancer)
04/2014 - 03/2000
6Hypoxia (Hypoxemia)
10/2008 - 04/2000
5Neoplasm Metastasis (Metastasis)
10/2009 - 10/2000
5Esophageal Neoplasms (Esophageal Cancer)
09/2008 - 01/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2014 - 07/2001
4Hepatocellular Carcinoma (Hepatoma)
11/2007 - 07/2000
4Breast Neoplasms (Breast Cancer)
11/2001 - 07/2000
4Melanoma (Melanoma, Malignant)
12/2000 - 01/2000
3Colorectal Neoplasms (Colorectal Cancer)
10/2009 - 09/2000
3Colonic Neoplasms (Colon Cancer)
10/2009 - 01/2001
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2006 - 02/2001
3Neutropenia
09/2002 - 07/2001
3Bone Resorption
03/2002 - 02/2000
2Fatigue
03/2016 - 10/2002
2Tuberculosis (Tuberculoses)
11/2009 - 11/2007
2Pulmonary Hypertension
10/2008 - 08/2001
2Inflammation (Inflammations)
10/2008 - 04/2000
2Pyoderma Gangrenosum
12/2007 - 04/2000
2Infections
11/2007 - 05/2006
2Carcinoma (Carcinomatosis)
06/2006 - 11/2001
2Hemorrhage
05/2006 - 03/2004
2Ulcer
05/2006 - 04/2000
2Leukoencephalopathies
07/2003 - 12/2002
2Fever (Fevers)
09/2002 - 07/2000
2Vomiting
11/2001 - 05/2001
2Tendon Injuries
10/2001 - 01/2001
2Leukopenia
07/2001 - 07/2000
1Skin Diseases (Skin Disease)
03/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1Dystonia (Limb Dystonia)
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
04/2014
1Adenocarcinoma of Lung
04/2014
1Testicular Neoplasms (Testicular Cancer)
04/2014
1Atrophy
07/2010
1Hemoperitoneum
09/2009

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
04/2014 - 06/2000
7Cisplatin (Platino)FDA LinkGeneric
10/2002 - 10/2000
6Irinotecan (Camptosar)FDA LinkGeneric
05/2006 - 02/2001
5Messenger RNA (mRNA)IBA
12/2001 - 06/2001
3Interleukin-8 (Interleukin 8)IBA
12/2007 - 04/2000
3EnzymesIBA
10/2001 - 07/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2000 - 04/2000
2Pharmaceutical PreparationsIBA
03/2022 - 08/2001
2AntigensIBA
04/2014 - 11/2009
2AntibodiesIBA
04/2014 - 04/2014
2Therapeutic UsesIBA
04/2014 - 02/2006
2Carboplatin (JM8)FDA LinkGeneric
05/2006 - 12/2001
2HSP40 Heat-Shock ProteinsIBA
03/2004 - 03/2001
2AutoantibodiesIBA
03/2004 - 03/2001
2Interleukin-6 (Interleukin 6)IBA
03/2003 - 09/2000
2Fluorouracil (Carac)FDA LinkGeneric
12/2002 - 10/2000
2CalciumIBA
03/2002 - 03/2000
2salicylhydroxamic acid (SHAM)IBA
03/2002 - 08/2001
25- bromo- N- (1- ethyl- 4- methylhexahydro- 1H- 1,4- diazepin- 6- yl)- 2- methoxy- 6- methylamino- 3- pyridinecarboxamide 2-fumarateIBA
11/2001 - 05/2001
2hydroxide ionIBA
11/2001 - 05/2001
2Topotecan (Hycamtin)FDA LinkGeneric
11/2001 - 02/2001
2polyvinyl alcohol hydrogelIBA
10/2001 - 01/2001
2Ligases (Synthetase)IBA
10/2001 - 04/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2001 - 02/2001
2DNA (Deoxyribonucleic Acid)IBA
04/2001 - 01/2000
2AutoantigensIBA
03/2001 - 01/2000
2Tumor Biomarkers (Tumor Markers)IBA
03/2001 - 01/2001
2CytokinesIBA
12/2000 - 04/2000
2Interleukin-12 (IL 12)IBA
12/2000 - 07/2000
2Telomerase (Telomerase Reverse Transcriptase)IBA
10/2000 - 05/2000
2Glucose (Dextrose)FDA LinkGeneric
09/2000 - 05/2000
2Cyclic GMPIBA
09/2000 - 05/2000
2BerberineIBA
09/2000 - 01/2000
2Biological ProductsIBA
07/2000 - 01/2000
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2018
1TabletsIBA
01/2018
1human ERBB2 proteinIBA
12/2014
1Infliximab (Remicade)FDA Link
04/2014
1Adalimumab (Humira)FDA Link
04/2014
1Immunoglobulins (Immunoglobulin)IBA
04/2014
1Neutralizing AntibodiesIBA
04/2014
1Immunoglobulin Allotypes (Immunoglobulin Allotype)IBA
04/2014
1AntralIBA
07/2010
1Small Interfering RNA (siRNA)IBA
10/2009
1Calcibiotic Root Canal SealerIBA
10/2009
1MonocrotalineIBA
10/2008
1Sildenafil Citrate (Viagra)FDA Link
10/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2008
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2008
1rho-Associated KinasesIBA
10/2008
1Indicators and Reagents (Reagents)IBA
09/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2008
1Vascular Endothelial Growth Factor CIBA
09/2008

Therapy/Procedure

8Therapeutics
10/2002 - 04/2000
5Drug Therapy (Chemotherapy)
05/2006 - 10/2000
3Esophagectomy
03/2004 - 06/2000
2Radiotherapy
10/2002 - 07/2001
2Intravenous Administration
08/2001 - 11/2000
2Hepatectomy
10/2000 - 10/2000
1Pallidotomy
01/2018
1Gastroenterostomy
03/2016
1Gastrectomy
03/2016
1Peritoneal Dialysis
09/2009